Inhaled Nitric Oxide for Clinical Management of COVID-19: A Systematic Review and Meta-Analysis

Background: Severe COVID-19 is associated with hypoxemia and acute respiratory distress syndrome (ARDS), which may predispose multiorgan failure and death. Inhaled nitric oxide (iNO) is a clinical vasodilator used in the management of acute respiratory distress syndrome (ARDS). This study evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Alqahtani, Jaber S., Aldhahir, Abdulelah M., Al Ghamdi, Shouq S., AlBahrani, Salma, AlDraiwiesh, Ibrahim A., Alqarni, Abdullah A., Latief, Kamaluddin, Raya, Reynie Purnama, Oyelade, Tope
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566710/
https://www.ncbi.nlm.nih.gov/pubmed/36232100
http://dx.doi.org/10.3390/ijerph191912803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566710/
https://www.ncbi.nlm.nih.gov/pubmed/36232100
http://dx.doi.org/10.3390/ijerph191912803

Ejemplares similares